Salvage therapy with decitabine in combination with granulocyte colony‐stimulating factor, low‐dose cytarabine, and aclarubicin in patients with refractory or relapsed early T‐cell precursor acute lymphoblastic leukemia

Abstract

The peer review history for this article is available at https://publons.com/publon/10.1002/hon.2783.